Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-10

Clinical Trial Update: Replagal Enzyme Replacement Therapy for Children With Fabry Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update for Replagal enzyme replacement therapy in children with Fabry disease; study completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Replagal (agalsidase alfa)

Snippet

Sponsor: Shire | Conditions: Fabry Disease | Phase 2 | Status: COMPLETED | Results posted: 2013-10-10